491 related articles for article (PubMed ID: 9655251)
1. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
3. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
5. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
6. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
7. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
8. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
[TBL] [Abstract][Full Text] [Related]
9. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E
Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
14. Activation of epidermal growth factor receptor during corneal epithelial migration.
Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
[TBL] [Abstract][Full Text] [Related]
15. Changes in protein expression during multistage mouse skin carcinogenesis.
Rundhaug JE; Gimenez-Conti I; Stern MC; Budunova IV; Kiguchi K; Bol DK; Coghlan LG; Conti CJ; DiGiovanni J; Fischer SM; Winberg LD; Slaga TJ
Mol Carcinog; 1997 Sep; 20(1):125-36. PubMed ID: 9328443
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
18. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
19. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines.
Ruck A; Paulie S
Anticancer Res; 1998; 18(3A):1447-52. PubMed ID: 9673354
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
Jhappan C; Takayama H; Dickson RB; Merlino G
Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
